ULTRA Global Supplement Development & Technology Transfer Center
Bridging the Gap Between Lab Formulation and Commercial Manufacturing
Supplement formulation, pilot trials & technology transfer support for global brands — before commercial manufacturing, market listing, registration, notification or local release.
From Concept to Scale
Many supplement projects encounter development challenges because laboratory-scale formulations do not always translate predictably into commercial manufacturing environments. Differences in equipment, processing parameters, ingredient behavior, production speeds and packaging systems can significantly influence product quality and commercialization timelines.
Laboratory Formulation
Small-scale concept validation
ULTRA
Commercial Manufacturing
Scalable, releasable, marketable
- Supported Dosage Forms
Tablets
Capsules
Softgels
Powders
Gummies
Pastilles
Chewable Tablets
Jelly Sticks
Functional Confectionery Products
- Quality System Backing
Supported by NSF cGMP and BRCGS quality system experience, ULTRA helps clients reduce development uncertainty, identify technical risks and prepare projects for successful commercialization through formulation development, pilot-scale validation, manufacturing feasibility assessment and technology transfer support.
What We Support
From formulation development to technology transfer — covering the full pre-commercialization technical readiness chain.
01
Formulation Development
- Formula design support
- Ingredient compatibility review
- Active ingredient loading assessment
- Multi-ingredient formulation planning
02
Dosage Form Development
- Dosage form selection
- Manufacturing practicality assessment
- Consumer usability considerations
- Packaging compatibility review
03
Pilot Trial Programs
- Laboratory samples
- Bench-scale evaluation
- Pilot-scale manufacturing trials
- Process optimization support
04
Technical Assessment
- Manufacturing feasibility reviews
- Preliminary stability screening
- Content uniformity pre-assessment
- Process development support
05
Documentation Support
- Product specification development
- Raw material specification suggestions
- Batch record preparation support
- Master Manufacturing Record (MMR) support
- Technical file preparation
06
Technology Transfer
ULTRA can assist clients preparing technical transfer packages for overseas manufacturers, local production partners or regional commercialization programs.
Technology transfer support may include:
- Product specifications
- Manufacturing process documentation
- Batch records
- Pilot trial reports
- Packaging specifications
- Stability reference information
- Technical development documentation
07
Development Data Package Readiness
ULTRA can support the preparation of development-stage technical documentation packages that may assist downstream manufacturers, sponsors, importers and regulatory consultants during commercialization planning.
Documentation support may include:
- Product specifications
- Pilot trial reports
- Raw material documentation reviews
- Batch records
- Packaging specifications
- Preliminary stability observations
- Technology transfer files
The scope of documentation support varies according to project requirements, dosage forms and intended target markets.
Market-Specific Development Programs
We provide targeted pre-development support to pave the way for downstream registration and monetization for our clients.
Australia AUST L Pre-Development
Development activities focus on formulation feasibility, pilot validation and R&D-stage data package readiness prior to sponsor review and commercialization planning.
- Formulation feasibility assessment
- Dosage form optimization
- Pilot-scale trials
- Preliminary stability screening
- Technical transfer documentation
Final ARTG listing, sponsor responsibilities, TGA GMP compliance confirmation, label review and commercial release remain subject to Australian regulatory requirements and the responsible Australian sponsor or authorized manufacturer.
U.S. Dietary Supplement Pre-Development
Development-stage documentation structures intended to facilitate downstream review by manufacturers or responsible parties against applicable U.S. dietary supplement manufacturing and documentation expectations.
- Formula development
- Supplement Facts planning
- Dosage form selection
- Pilot-scale evaluation
- Preliminary specifications
- Packaging assessment
- Documentation preparation
Final compliance remains the responsibility of the brand owner, importer or responsible party — including label review, structure/function claims, NDI assessment where applicable, FTC compliance, California Proposition 65 considerations and commercial release requirements.
EU Food Supplement Pre-Development
Development support assists commercialization planning and technical readiness before country-specific regulatory review processes begin.
- Formula development
- Vitamin and mineral combination review
- Botanical ingredient assessment
- Amino acid formulation planning
- Packaging evaluation
- Preliminary stability screening
- Technical documentation support
Final compliance remains subject to country-specific requirements, importer responsibilities, Novel Food considerations, notification procedures and applicable health claim regulations.
Canada NHP Pre-Development
Development activities assist technical preparation prior to NPN application review by the responsible Canadian party.
- Formula planning
- Active ingredient review
- Dosage form development
- Product specification preparation
- Preliminary stability assessment
- Technical package preparation
Final NPN applications, importer obligations, site licensing requirements and market authorization remain the responsibility of the Canadian responsible party.
Why Use ULTRA for Early-Stage Development?
Developing a supplement directly through commercial manufacturing can be expensive, time-consuming and technically challenging. Many projects encounter avoidable formulation, process or scale-up issues after significant resources have already been committed. ULTRA helps identify and mitigate these risks earlier.
Manufacturing Scale-Up Feasibility
Can a formulation maintain performance, content uniformity, processability and product quality when transferred from pilot-scale development to commercial manufacturing?
Can potential scale-up variability be identified and addressed before full commercial production begins?
Ingredient Compatibility Assessment
Will active ingredients remain compatible within the selected dosage form, processing conditions and packaging system?
Organoleptic & Stability Considerations
Are there taste, texture, moisture sensitivity or packaging compatibility factors that should be reviewed before commercialization?
Development Data Package Readiness
Will downstream manufacturers, sponsors, importers or regulatory consultants have access to the technical documentation required to support commercialization planning and technology transfer activities?
By addressing these variables before commercialization, brands can often reduce development waste, shorten project timelines and improve manufacturing readiness.
Typical Development Workflow
A structured 9-step development path from product concept to downstream production interface
Step 1
Step 2
Step 3
Step 4
Step 5
Step 6
Step 7
Step 8
Step 9
Referenced International Frameworks
ULTRA development programs are commonly structured with consideration for these international supplement manufacturing and commercialization frameworks.
United States
FDA 21 CFR Part 111
Dietary Supplements
US
Australia
Therapeutic Goods Act 1989
ARTG Listed Medicine requirements · TGA GMP evidence expectations
AU
European Union
Regulation (EC) No 178/2002 & Directive 2002/46/EC
Food supplement-related development considerations
EU
Canada
NHPR
Natural Health Products Regulations
CA
Project-specific regulatory obligations remain the responsibility of the relevant sponsor, importer, manufacturer, licence holder or regulatory consultant.
Scope Boundaries
ULTRA’s development and technology transfer services are designed to support formulation development, pilot validation and commercialization readiness. The following are explicitly outside our service scope.
Market-specific product registration, listing or notification procedures
Sponsor, importer or licence-holder responsibilities
Final label review and approval
Local GMP manufacturing authorization or product release
Market-specific legal, regulatory or compliance advice
Claims substantiation, advertising review or commercial approval processes
Who Is This For
Flexible development support for brand owners, importers, start-ups, cross-border e-commerce and beyond.
Supplement brand owners developing new products
Importers seeking to reduce development costs
Regulatory consultants supporting client projects
Overseas manufacturers requiring technical transfer documentation
Practitioner-focused supplement brands
Start-up companies validating new product concepts before commercialization
Amazon sellers launching supplement brands
Shopify and DTC wellness brands
TikTok Shop supplement sellers
Ready to Start Your Project?
Our team will review your project and provide preliminary development recommendations, technical risk observations and pilot-trial pathway suggestions.